“We are taking decisive and intentional actions to drive business improvement,” said
First Quarter 2026 Financial Highlights:
|
Three Months Ended |
|||||||
|
|
|
|
|
|
|||
|
(unaudited) |
|||||||
|
(In $ millions, except per share data) |
|||||||
|
|
|
|
|
|
|||
Engineered Materials |
|
1,325 |
|
|
1,277 |
|
|
1,287 |
Acetyl Chain |
|
1,036 |
|
|
940 |
|
|
1,116 |
Intersegment Eliminations |
|
(24) |
|
|
(13) |
|
|
(14) |
Total |
|
2,337 |
|
|
2,204 |
|
|
2,389 |
|
|
|
|
|
|
|||
Operating Profit (Loss) |
|
|
|
|
|
|||
Engineered Materials |
|
221 |
|
|
111 |
|
|
94 |
Acetyl Chain |
|
95 |
|
|
90 |
|
|
161 |
Other Activities |
|
(102) |
|
|
(108) |
|
|
(90) |
Total |
|
214 |
|
|
93 |
|
|
165 |
|
|
|
|
|
|
|||
Net Earnings (Loss) |
|
48 |
|
|
22 |
|
|
(20) |
|
|
|
|
|
|
|||
Adjusted EBIT(1) |
|
|
|
|
|
|||
Engineered Materials |
|
220 |
|
|
183 |
|
|
124 |
Acetyl Chain |
|
131 |
|
|
146 |
|
|
167 |
Other Activities |
|
(76) |
|
|
(78) |
|
|
(60) |
Total |
|
275 |
|
|
251 |
|
|
231 |
|
|
|
|
|
|
|||
Equity Earnings and Dividend Income, Other Income (Expense) |
|
|
|
|
|
|||
Engineered Materials |
|
32 |
|
|
32 |
|
|
17 |
Acetyl Chain |
|
2 |
|
|
42 |
|
|
3 |
|
|
|
|
|
|
|||
Operating EBITDA(1) |
|
455 |
|
|
435 |
|
|
411 |
Diluted EPS - continuing operations |
$ |
0.41 |
|
$ |
0.23 |
|
$ |
(0.17) |
Diluted EPS - total |
$ |
0.40 |
|
$ |
0.17 |
|
$ |
(0.22) |
Adjusted EPS(1) |
$ |
0.85 |
|
$ |
0.67 |
|
$ |
0.54 |
|
|
|
|
|
|
|||
Net cash provided by (used in) investing activities |
|
425 |
|
|
(104) |
|
|
(98) |
Net cash provided by (used in) financing activities |
|
(3) |
|
|
(324) |
|
|
45 |
Net cash provided by (used in) operating activities |
|
76 |
|
|
252 |
|
|
37 |
Free cash flow(1) |
|
3 |
|
|
160 |
|
|
(73) |
(1) See "Non-US GAAP Financial Measures" below. |
||||||||
Recent Highlights:
First Quarter Business Segment Overview
Engineered Materials
Engineered Materials reported first quarter net sales of
Acetyl Chain
The Acetyl Chain reported first quarter net sales of
Cash Flow and Tax
The effective
The effective tax rate for 2026 adjusted earnings was 8 percent for the first quarter. We anticipate this rate for the full year 2026 based on expected jurisdictional earnings mix for the full year and consideration of other non-recurring
Outlook
"We are uniquely positioned to create and capture opportunities, and as we move into the second quarter, we expect meaningful sequential improvement driven by stronger volumes and price increase realization in the Acetyl Chain, along with pricing improvements in Engineered Materials and seasonal demand across both businesses." continued Richardson. "Based on this, we expect second quarter adjusted earnings per share to be
“These actions are expected to strengthen earnings in 2026, meaningfully accelerate deleveraging, and bring our net debt to operating EBITDA ratio into the vicinity of 4.8x. Across market cycles, execution of our priorities positions
Reconciliations of forecasted non-GAAP measures such as adjusted earnings per share, adjusted EBIT, operating EBITDA or free cash flow to the equivalent
The Company's prepared remarks related to the first quarter will be posted on its website at investors.celanese.com under
Forward-Looking Statements
This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, deleveraging efforts, planned cost reductions, dividend policy, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: the ability to successfully achieve planned cost reductions; changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; our level of indebtedness and our financial condition, each of which could diminish our ability to raise additional capital to fund operations, reduce our business and strategic flexibility, increase our interest expense, limit the success of our deleveraging efforts, and impact changes to our credit ratings, which could increase our interest expense in the event of additional downgrades; volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine, Polyamide 66 ("PA66"), polybutylene terephthalate, ethanol, natural gas and fuel oil, and the prices for electricity and other energy sources; the ability to pass increases in raw materials prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; the possibility that we will not be able to realize the anticipated benefits of the Mobility & Materials business (the "M&
Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Non-GAAP Financial Measures
Presentation
This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.
Use of Non-US GAAP Financial Information
This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to
Definitions of Non-US GAAP Financial Measures
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
Reconciliation of Non-US GAAP Financial Measures
Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
Certain prior period amounts have been revised to correct for certain prior period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for the quarterly period ending
Supplemental Information
Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document.
Consolidated Statements of Operations - Unaudited |
|||||
|
Three Months Ended |
||||
|
|
|
|
|
|
|
(In $ millions, except share and per share data) |
||||
Net sales |
2,337 |
|
2,204 |
|
2,389 |
Cost of sales |
(1,869) |
|
(1,781) |
|
(1,915) |
Gross profit |
468 |
|
423 |
|
474 |
Selling, general and administrative expenses |
(226) |
|
(223) |
|
(231) |
Amortization of intangible assets |
(40) |
|
(40) |
|
(40) |
Research and development expenses |
(28) |
|
(32) |
|
(31) |
Other (charges) gains, net |
(20) |
|
(39) |
|
(31) |
Foreign exchange gain (loss), net |
12 |
|
7 |
|
21 |
Gain (loss) on disposition of businesses and assets, net |
48 |
|
(3) |
|
3 |
Operating profit (loss) |
214 |
|
93 |
|
165 |
Equity in net earnings (loss) of affiliates |
35 |
|
37 |
|
22 |
Non-operating pension and other postretirement employee benefit (expense) income |
5 |
|
50 |
|
2 |
Interest expense |
(183) |
|
(177) |
|
(170) |
Refinancing expense |
— |
|
(36) |
|
(32) |
Interest income |
9 |
|
6 |
|
4 |
Dividend income - equity investments |
1 |
|
40 |
|
1 |
Other income (expense), net |
1 |
|
— |
|
2 |
Earnings (loss) from continuing operations before tax |
82 |
|
13 |
|
(6) |
Income tax (provision) benefit |
(33) |
|
15 |
|
(9) |
Earnings (loss) from continuing operations |
49 |
|
28 |
|
(15) |
Earnings (loss) from operation of discontinued operations |
(1) |
|
(8) |
|
(6) |
Income tax (provision) benefit from discontinued operations |
— |
|
2 |
|
1 |
Earnings (loss) from discontinued operations |
(1) |
|
(6) |
|
(5) |
Net earnings (loss) |
48 |
|
22 |
|
(20) |
Net (earnings) loss attributable to noncontrolling interests |
(4) |
|
(3) |
|
(4) |
Net earnings (loss) attributable to |
44 |
|
19 |
|
(24) |
Amounts attributable to |
|
|
|
|
|
Earnings (loss) from continuing operations |
45 |
|
25 |
|
(19) |
Earnings (loss) from discontinued operations |
(1) |
|
(6) |
|
(5) |
Net earnings (loss) |
44 |
|
19 |
|
(24) |
Earnings (loss) per common share - basic |
|
|
|
|
|
Continuing operations |
0.41 |
|
0.23 |
|
(0.17) |
Discontinued operations |
(0.01) |
|
(0.06) |
|
(0.05) |
Net earnings (loss) - basic |
0.40 |
|
0.17 |
|
(0.22) |
Earnings (loss) per common share - diluted |
|
|
|
|
|
Continuing operations |
0.41 |
|
0.23 |
|
(0.17) |
Discontinued operations |
(0.01) |
|
(0.06) |
|
(0.05) |
Net earnings (loss) - diluted |
0.40 |
|
0.17 |
|
(0.22) |
Weighted average shares (in millions) |
|
|
|
|
|
Basic |
109.7 |
|
109.6 |
|
109.4 |
Diluted |
110.0 |
|
109.8 |
|
109.4 |
Consolidated Balance Sheets - Unaudited |
|||
|
As of
|
|
As of
|
|
|||
|
(In $ millions) |
||
ASSETS |
|
|
|
Current Assets |
|
|
|
Cash and cash equivalents |
1,758 |
|
1,263 |
Trade receivables - third party and affiliates, net |
1,097 |
|
922 |
Non-trade receivables, net |
583 |
|
545 |
Inventories |
2,284 |
|
2,220 |
Assets held for sale |
— |
|
492 |
Other assets |
247 |
|
251 |
Total current assets |
5,969 |
|
5,693 |
Investments in affiliates |
1,227 |
|
1,252 |
Property, plant and equipment, net |
4,938 |
|
5,076 |
Operating lease right-of-use assets |
376 |
|
359 |
Deferred income taxes |
1,341 |
|
1,359 |
Other assets |
608 |
|
601 |
|
4,157 |
|
4,171 |
Intangible assets, net |
3,119 |
|
3,184 |
Total assets |
21,735 |
|
21,695 |
LIABILITIES AND EQUITY |
|
|
|
Current Liabilities |
|
|
|
Short-term borrowings and current installments of long-term debt - third party and affiliates |
1,741 |
|
1,204 |
Trade payables - third party and affiliates |
1,441 |
|
1,279 |
Liabilities held for sale |
— |
|
75 |
Other liabilities |
1,040 |
|
1,049 |
Income taxes payable |
94 |
|
76 |
Total current liabilities |
4,316 |
|
3,683 |
Long-term debt, net of unamortized deferred financing costs |
10,813 |
|
11,394 |
Deferred income taxes |
512 |
|
512 |
Uncertain tax positions |
225 |
|
208 |
Benefit obligations |
332 |
|
344 |
Operating lease liabilities |
275 |
|
265 |
Other liabilities |
777 |
|
817 |
Commitments and Contingencies |
|
|
|
Shareholders' Equity |
|
|
|
|
(5,482) |
|
(5,482) |
Additional paid-in capital |
439 |
|
431 |
Retained earnings |
9,917 |
|
9,876 |
Accumulated other comprehensive income (loss), net |
(811) |
|
(776) |
|
4,063 |
|
4,049 |
Noncontrolling interests |
422 |
|
423 |
Total equity |
4,485 |
|
4,472 |
Total liabilities and equity |
21,735 |
|
21,695 |
Non-
In this document, the terms the "Company," "we" and "our" refer to
Purpose
The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-
Presentation
This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.
Use of Non-
From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("
Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other
Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the
This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.
Specific Measures Used
This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to
Definitions
Supplemental Information
Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
Certain prior period amounts have been revised to correct for certain prior period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for the quarterly period ending
Table 1 Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited |
|||||||||||||||||
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||
|
(In $ millions) |
||||||||||||||||
Net earnings (loss) attributable to |
44 |
|
|
(1,165 |
) |
|
19 |
|
|
(1,357 |
) |
|
197 |
|
|
(24 |
) |
(Earnings) loss from discontinued operations |
1 |
|
|
21 |
|
|
6 |
|
|
— |
|
|
10 |
|
|
5 |
|
Interest income |
(9 |
) |
|
(24 |
) |
|
(6 |
) |
|
(7 |
) |
|
(7 |
) |
|
(4 |
) |
Interest expense |
183 |
|
|
701 |
|
|
177 |
|
|
177 |
|
|
177 |
|
|
170 |
|
Refinancing expense |
— |
|
|
68 |
|
|
36 |
|
|
— |
|
|
— |
|
|
32 |
|
Income tax provision (benefit) |
33 |
|
|
(90 |
) |
|
(15 |
) |
|
(7 |
) |
|
(77 |
) |
|
9 |
|
Certain Items attributable to |
23 |
|
|
1,639 |
|
|
34 |
|
|
1,520 |
|
|
42 |
|
|
43 |
|
Adjusted EBIT |
275 |
|
|
1,150 |
|
|
251 |
|
|
326 |
|
|
342 |
|
|
231 |
|
Depreciation and amortization expense(1) |
180 |
|
|
743 |
|
|
184 |
|
|
191 |
|
|
188 |
|
|
180 |
|
Operating EBITDA |
455 |
|
|
1,893 |
|
|
435 |
|
|
517 |
|
|
530 |
|
|
411 |
|
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||
|
(In $ millions) |
||||||||||||||||
Engineered Materials |
3 |
|
|
6 |
|
|
1 |
|
|
3 |
|
|
2 |
|
|
— |
|
Acetyl Chain |
18 |
|
|
11 |
|
|
11 |
|
|
— |
|
|
— |
|
|
— |
|
Other Activities(2) |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Accelerated depreciation and amortization expense |
21 |
|
|
17 |
|
|
12 |
|
|
3 |
|
|
2 |
|
|
— |
|
Depreciation and amortization expense(1) |
180 |
|
|
743 |
|
|
184 |
|
|
191 |
|
|
188 |
|
|
180 |
|
Total depreciation and amortization expense |
201 |
|
|
760 |
|
|
196 |
|
|
194 |
|
|
190 |
|
|
180 |
|
______________________________ |
|
(1) |
Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above. |
(2) |
Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
Table 2 |
|||||||||||||||||||||||||||||||||||
Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited |
|||||||||||||||||||||||||||||||||||
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||||||||||||||||||||
|
(In $ millions, except percentages) |
||||||||||||||||||||||||||||||||||
Operating Profit (Loss) / Operating Margin |
|||||||||||||||||||||||||||||||||||
Engineered Materials |
221 |
|
|
16.7 |
% |
|
(958 |
) |
|
(17.8 |
)% |
|
111 |
|
|
8.7 |
% |
|
(1,327 |
) |
|
(95.9 |
)% |
|
164 |
|
|
11.4 |
% |
|
94 |
|
|
7.3 |
% |
Acetyl Chain |
95 |
|
|
9.2 |
% |
|
539 |
|
|
12.7 |
% |
|
90 |
|
|
9.6 |
% |
|
135 |
|
|
12.7 |
% |
|
153 |
|
|
13.7 |
% |
|
161 |
|
|
14.4 |
% |
Other Activities(1) |
(102 |
) |
|
|
|
(367 |
) |
|
|
|
(108 |
) |
|
|
|
(83 |
) |
|
|
|
(86 |
) |
|
|
|
(90 |
) |
|
|
||||||
Total |
214 |
|
|
9.2 |
% |
|
(786 |
) |
|
(8.2 |
)% |
|
93 |
|
|
4.2 |
% |
|
(1,275 |
) |
|
(52.7 |
)% |
|
231 |
|
|
9.1 |
% |
|
165 |
|
|
6.9 |
% |
Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials |
2 |
|
|
|
|
6 |
|
|
|
|
— |
|
|
|
|
3 |
|
|
|
|
1 |
|
|
|
|
2 |
|
|
|
||||||
Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain |
2 |
|
|
|
|
8 |
|
|
|
|
3 |
|
|
|
|
1 |
|
|
|
|
2 |
|
|
|
|
2 |
|
|
|
||||||
Operating Profit (Loss) Attributable to |
210 |
|
|
9.0 |
% |
|
(800 |
) |
|
(8.4 |
)% |
|
90 |
|
|
4.1 |
% |
|
(1,279 |
) |
|
(52.9 |
)% |
|
228 |
|
|
9.0 |
% |
|
161 |
|
|
6.7 |
% |
Operating Profit (Loss) / Operating Margin Attributable to |
|||||||||||||||||||||||||||||||||||
Engineered Materials |
219 |
|
|
16.5 |
% |
|
(964 |
) |
|
(17.9 |
)% |
|
111 |
|
|
8.7 |
% |
|
(1,330 |
) |
|
(96.1 |
)% |
|
163 |
|
|
11.3 |
% |
|
92 |
|
|
7.1 |
% |
Acetyl Chain |
93 |
|
|
9.0 |
% |
|
531 |
|
|
12.5 |
% |
|
87 |
|
|
9.3 |
% |
|
134 |
|
|
12.6 |
% |
|
151 |
|
|
13.5 |
% |
|
159 |
|
|
14.2 |
% |
Other Activities(1) |
(102 |
) |
|
|
|
(367 |
) |
|
|
|
(108 |
) |
|
|
|
(83 |
) |
|
|
|
(86 |
) |
|
|
|
(90 |
) |
|
|
||||||
Total |
210 |
|
|
9.0 |
% |
|
(800 |
) |
|
(8.4 |
)% |
|
90 |
|
|
4.1 |
% |
|
(1,279 |
) |
|
(52.9 |
)% |
|
228 |
|
|
9.0 |
% |
|
161 |
|
|
6.7 |
% |
Equity Earnings and Dividend Income, Other Income (Expense) Attributable to |
|||||||||||||||||||||||||||||||||||
Engineered Materials |
32 |
|
|
|
|
109 |
|
|
|
|
32 |
|
|
|
|
35 |
|
|
|
|
25 |
|
|
|
|
17 |
|
|
|
||||||
Acetyl Chain |
2 |
|
|
|
|
132 |
|
|
|
|
42 |
|
|
|
|
44 |
|
|
|
|
43 |
|
|
|
|
3 |
|
|
|
||||||
Other Activities(1) |
3 |
|
|
|
|
15 |
|
|
|
|
3 |
|
|
|
|
4 |
|
|
|
|
3 |
|
|
|
|
5 |
|
|
|
||||||
Total |
37 |
|
|
|
|
256 |
|
|
|
|
77 |
|
|
|
|
83 |
|
|
|
|
71 |
|
|
|
|
25 |
|
|
|
||||||
Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to |
|||||||||||||||||||||||||||||||||||
Engineered Materials |
— |
|
|
|
|
3 |
|
|
|
|
3 |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
||||||
Acetyl Chain |
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
||||||
Other Activities(1) |
5 |
|
|
|
|
52 |
|
|
|
|
47 |
|
|
|
|
2 |
|
|
|
|
1 |
|
|
|
|
2 |
|
|
|
||||||
Total |
5 |
|
|
|
|
55 |
|
|
|
|
50 |
|
|
|
|
2 |
|
|
|
|
1 |
|
|
|
|
2 |
|
|
|
||||||
Certain Items Attributable to |
|||||||||||||||||||||||||||||||||||
Engineered Materials |
(31 |
) |
|
|
|
1,572 |
|
|
|
|
37 |
|
|
|
|
1,495 |
|
|
|
|
25 |
|
|
|
|
15 |
|
|
|
||||||
Acetyl Chain |
36 |
|
|
|
|
32 |
|
|
|
|
17 |
|
|
|
|
9 |
|
|
|
|
1 |
|
|
|
|
5 |
|
|
|
||||||
Other Activities(1) |
18 |
|
|
|
|
35 |
|
|
|
|
(20 |
) |
|
|
|
16 |
|
|
|
|
16 |
|
|
|
|
23 |
|
|
|
||||||
Total |
23 |
|
|
|
|
1,639 |
|
|
|
|
34 |
|
|
|
|
1,520 |
|
|
|
|
42 |
|
|
|
|
43 |
|
|
|
||||||
Adjusted EBIT / Adjusted EBIT Margin |
|||||||||||||||||||||||||||||||||||
Engineered Materials |
220 |
|
|
16.6 |
% |
|
720 |
|
|
13.4 |
% |
|
183 |
|
|
14.3 |
% |
|
200 |
|
|
14.5 |
% |
|
213 |
|
|
14.8 |
% |
|
124 |
|
|
9.6 |
% |
Acetyl Chain |
131 |
|
|
12.6 |
% |
|
695 |
|
|
16.4 |
% |
|
146 |
|
|
15.5 |
% |
|
187 |
|
|
17.6 |
% |
|
195 |
|
|
17.5 |
% |
|
167 |
|
|
15.0 |
% |
Other Activities(1) |
(76 |
) |
|
|
|
(265 |
) |
|
|
|
(78 |
) |
|
|
|
(61 |
) |
|
|
|
(66 |
) |
|
|
|
(60 |
) |
|
|
||||||
Total |
275 |
|
|
11.8 |
% |
|
1,150 |
|
|
12.0 |
% |
|
251 |
|
|
11.4 |
% |
|
326 |
|
|
13.5 |
% |
|
342 |
|
|
13.5 |
% |
|
231 |
|
|
9.7 |
% |
______________________________ |
|
(1) |
Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
Table 2 |
|||||||||||||||||||||||||||||||||||
Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.) |
|||||||||||||||||||||||||||||||||||
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||||||||||||||||||||
|
(In $ millions, except percentages) |
||||||||||||||||||||||||||||||||||
Depreciation and Amortization Expense(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Engineered Materials |
104 |
|
|
|
|
441 |
|
|
|
|
105 |
|
|
|
|
115 |
|
|
|
|
112 |
|
|
|
|
109 |
|
|
|
||||||
Acetyl Chain |
63 |
|
|
|
|
252 |
|
|
|
|
64 |
|
|
|
|
63 |
|
|
|
|
64 |
|
|
|
|
61 |
|
|
|
||||||
Other Activities(2) |
13 |
|
|
|
|
50 |
|
|
|
|
15 |
|
|
|
|
13 |
|
|
|
|
12 |
|
|
|
|
10 |
|
|
|
||||||
Total |
180 |
|
|
|
|
743 |
|
|
|
|
184 |
|
|
|
|
191 |
|
|
|
|
188 |
|
|
|
|
180 |
|
|
|
||||||
Operating EBITDA / Operating EBITDA Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Engineered Materials |
324 |
|
|
24.5 |
% |
|
1,161 |
|
|
21.5 |
% |
|
288 |
|
|
22.6 |
% |
|
315 |
|
|
22.8 |
% |
|
325 |
|
|
22.5 |
% |
|
233 |
|
|
18.1 |
% |
Acetyl Chain |
194 |
|
|
18.7 |
% |
|
947 |
|
|
22.4 |
% |
|
210 |
|
|
22.3 |
% |
|
250 |
|
|
23.6 |
% |
|
259 |
|
|
23.2 |
% |
|
228 |
|
|
20.4 |
% |
Other Activities(2) |
(63 |
) |
|
|
|
(215 |
) |
|
|
|
(63 |
) |
|
|
|
(48 |
) |
|
|
|
(54 |
) |
|
|
|
(50 |
) |
|
|
||||||
Total |
455 |
|
|
19.5 |
% |
|
1,893 |
|
|
19.8 |
% |
|
435 |
|
|
19.7 |
% |
|
517 |
|
|
21.4 |
% |
|
530 |
|
|
20.9 |
% |
|
411 |
|
|
17.2 |
% |
______________________________ |
|
(1) |
Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details. |
(2) |
Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
Table 3 |
|||||||||||||||||||||||||||||||||||
Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited |
|||||||||||||||||||||||||||||||||||
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||||||||||||||||||||
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
||||||||||||
|
(In $ millions, except per share data) |
||||||||||||||||||||||||||||||||||
Earnings (loss) from continuing operations attributable to |
45 |
|
|
0.41 |
|
(1,144 |
) |
|
(10.44 |
) |
|
25 |
|
|
0.23 |
|
(1,357 |
) |
|
(12.39 |
) |
|
207 |
|
|
1.89 |
|
(19 |
) |
|
(0.17 |
) |
|||
Income tax provision (benefit) |
33 |
|
|
|
|
(90 |
) |
|
|
|
(15 |
) |
|
|
|
(7 |
) |
|
|
|
(77 |
) |
|
|
|
9 |
|
|
|
||||||
Earnings (loss) from continuing operations before tax |
78 |
|
|
|
|
(1,234 |
) |
|
|
|
10 |
|
|
|
|
(1,364 |
) |
|
|
|
130 |
|
|
|
|
(10 |
) |
|
|
||||||
Certain Items attributable to |
23 |
|
|
|
|
1,639 |
|
|
|
|
34 |
|
|
|
|
1,520 |
|
|
|
|
42 |
|
|
|
|
43 |
|
|
|
||||||
Refinancing and related expenses |
— |
|
|
|
68 |
|
|
|
|
36 |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
32 |
|
|
|
|||||||
Adjusted earnings (loss) from continuing operations before tax |
101 |
|
|
|
|
473 |
|
|
|
|
80 |
|
|
|
|
156 |
|
|
|
|
172 |
|
|
|
|
65 |
|
|
|
||||||
Income tax (provision) benefit on adjusted earnings(1) |
(8 |
) |
|
|
|
(36 |
) |
|
|
|
(6 |
) |
|
|
|
(9 |
) |
|
|
|
(15 |
) |
|
|
|
(6 |
) |
|
|
||||||
Adjusted earnings (loss) from continuing operations(2) |
93 |
|
|
0.85 |
|
437 |
|
|
3.98 |
|
|
74 |
|
|
0.67 |
|
147 |
|
|
1.34 |
|
|
157 |
|
|
1.43 |
|
59 |
|
|
0.54 |
|
|||
|
Diluted shares (in millions)(3) |
||||||||||||||||||||||||||||||||||
Weighted average shares outstanding |
109.7 |
|
|
|
|
109.5 |
|
|
|
|
109.6 |
|
|
|
|
109.6 |
|
|
|
|
109.5 |
|
|
|
|
109.4 |
|
|
|
||||||
Incremental shares attributable to equity awards |
0.3 |
|
|
|
|
0.2 |
|
|
|
|
0.2 |
|
|
|
|
— |
|
|
|
|
0.2 |
|
|
|
|
— |
|
|
|
||||||
Total diluted shares |
110.0 |
|
|
|
|
109.7 |
|
|
|
|
109.8 |
|
|
|
|
109.6 |
|
|
|
|
109.7 |
|
|
|
|
109.4 |
|
|
|
||||||
______________________________ |
|
(1) |
Calculated using adjusted effective tax rates (Table 3a) as follows: |
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|||||||||||||
|
|
|||||||||||||||||||||||
Adjusted effective tax rate |
8 |
|
|
|
8 |
|
|
|
8 |
|
|
|
6 |
|
|
|
9 |
|
|
|
9 |
|
|
|
(2) |
Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns. |
|
|
Actual Plan Asset Returns |
|
Expected Plan Asset Returns |
|||
|
|
(In percentages) |
|||||
2025 |
|
7.8 |
|
5.3 |
|||
(3) |
Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive. |
Table 3a |
|||||
Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited |
|||||
|
Estimated |
|
Actual |
||
|
2026 |
|
2025 |
||
|
(In percentages) |
||||
|
16 |
|
|
7 |
|
Discrete quarterly recognition of GAAP items(1) |
(6 |
) |
|
17 |
|
Tax impact of other charges and adjustments(2) |
1 |
|
|
(12 |
) |
Utilization of foreign tax credits |
(1 |
) |
|
— |
|
Changes in valuation allowances, excluding impact of other charges and adjustments(3) |
(3 |
) |
|
(12 |
) |
Other, includes effect of discrete current year transactions(4) |
1 |
|
|
8 |
|
Adjusted tax rate |
8 |
|
|
8 |
|
______________________________ |
|
Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate for actual results. |
|
(1) |
Such as changes in tax laws (including |
(2) |
Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes. |
(3) |
Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments. |
(4) |
Includes tax impacts related to full-year actual tax opportunities and related costs, as well as current year realization of |
Table 4 |
|||||||||||||||||
|
|||||||||||||||||
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||
|
(In $ millions) |
||||||||||||||||
Engineered Materials |
1,325 |
|
|
5,390 |
|
|
1,277 |
|
|
1,384 |
|
|
1,442 |
|
|
1,287 |
|
Acetyl Chain |
1,036 |
|
|
4,232 |
|
|
940 |
|
|
1,061 |
|
|
1,115 |
|
|
1,116 |
|
Intersegment eliminations(1) |
(24 |
) |
|
(78 |
) |
|
(13 |
) |
|
(26 |
) |
|
(25 |
) |
|
(14 |
) |
Net sales |
2,337 |
|
|
9,544 |
|
|
2,204 |
|
|
2,419 |
|
|
2,532 |
|
|
2,389 |
|
______________________________ |
|
(1) |
Includes intersegment sales primarily related to the Acetyl Chain. |
Table 4a |
|||||||||||
Factors Affecting Segment Net Sales Sequentially - Unaudited |
|||||||||||
|
|||||||||||
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
3 |
|
— |
|
1 |
|
4 |
|
|||
Acetyl Chain |
8 |
|
1 |
|
1 |
|
10 |
|
|||
|
|
|
|
|
|
|
|
|
|||
|
5 |
|
— |
|
1 |
|
6 |
|
|||
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
(6 |
) |
|
(2 |
) |
|
— |
|
(8 |
) |
|
Acetyl Chain |
(10 |
) |
|
(1 |
) |
|
— |
|
(11 |
) |
|
|
|
|
|
|
|
|
|
||||
|
(7 |
) |
|
(2 |
) |
|
— |
|
(9 |
) |
|
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
(6 |
) |
|
1 |
|
|
1 |
|
(4 |
) |
|
Acetyl Chain |
(2 |
) |
|
(4 |
) |
|
1 |
|
(5 |
) |
|
|
|
|
|
|
|
|
|
||||
|
(4 |
) |
|
(1 |
) |
|
1 |
|
(4 |
) |
|
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
9 |
|
|
— |
|
|
3 |
|
12 |
||
Acetyl Chain |
(1 |
) |
|
(2 |
) |
|
3 |
|
— |
||
|
|
|
|
|
|
|
|
||||
|
4 |
|
|
(1 |
) |
|
3 |
|
6 |
||
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
— |
|
2 |
|
|
(1 |
) |
|
1 |
|
|
Acetyl Chain |
3 |
|
(1 |
) |
|
(1 |
) |
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
2 |
|
— |
|
|
(1 |
) |
|
1 |
|
|
Table 4b |
|||||||||||
Factors Affecting Segment Net Sales Year Over Year - Unaudited |
|||||||||||
|
|||||||||||
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
— |
|
|
(1 |
) |
|
4 |
|
3 |
|
|
Acetyl Chain |
(7 |
) |
|
(4 |
) |
|
4 |
|
(7 |
) |
|
|
|
|
|
|
|
|
|
||||
|
(3 |
) |
|
(3 |
) |
|
4 |
|
(2 |
) |
|
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
(2 |
) |
|
— |
|
|
3 |
|
1 |
|
|
Acetyl Chain |
(10 |
) |
|
(7 |
) |
|
2 |
|
(15 |
) |
|
|
|
|
|
|
|
|
|
||||
|
(6 |
) |
|
(3 |
) |
|
2 |
|
(7 |
) |
|
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
(8 |
) |
|
(1 |
) |
|
2 |
|
(7 |
) |
|
Acetyl Chain |
(4 |
) |
|
(8 |
) |
|
1 |
|
(11 |
) |
|
|
|
|
|
|
|
|
|
||||
|
(6 |
) |
|
(4 |
) |
|
1 |
|
(9 |
) |
|
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
(3 |
) |
|
(1 |
) |
|
2 |
|
(2 |
) |
|
Acetyl Chain |
(2 |
) |
|
(7 |
) |
|
2 |
|
(7 |
) |
|
|
|
|
|
|
|
|
|
||||
|
(2 |
) |
(4 |
) |
2 |
(4 |
) |
||||
Three Months Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
(4 |
) |
|
(2 |
) |
|
(1 |
) |
|
(7 |
) |
Acetyl Chain |
(6 |
) |
|
(4 |
) |
|
(1 |
) |
|
(11 |
) |
|
|
|
|
|
|
|
|
||||
|
(5 |
) |
|
(3 |
) |
|
(1 |
) |
|
(9 |
) |
Table 4c |
|||||||||||
Factors Affecting Segment Net Sales Year Over Year - Unaudited |
|||||||||||
|
|||||||||||
Year Ended |
|||||||||||
|
Volume |
|
Price |
|
Currency |
|
Total |
||||
|
(In percentages) |
||||||||||
Engineered Materials |
(4 |
) |
|
(1 |
) |
|
1 |
|
(4 |
) |
|
Acetyl Chain |
(6 |
) |
|
(6 |
) |
|
1 |
|
(11 |
) |
|
|
|
|
|
|
|
|
|
||||
|
(4 |
) |
|
(4 |
) |
|
1 |
|
(7 |
) |
|
Table 5 |
|||||||||||||||||
Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited |
|||||||||||||||||
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||
|
(In $ millions, except percentages) |
||||||||||||||||
Net cash provided by (used in) investing activities |
425 |
|
|
(349 |
) |
|
(104 |
) |
|
(59 |
) |
|
(88 |
) |
|
(98 |
) |
Net cash provided by (used in) financing activities |
(3 |
) |
|
(513 |
) |
|
(324 |
) |
|
(118 |
) |
|
(116 |
) |
|
45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Net cash provided by (used in) operating activities |
76 |
|
|
1,146 |
|
|
252 |
|
|
447 |
|
|
410 |
|
|
37 |
|
Capital expenditures on property, plant and equipment |
(66 |
) |
|
(343 |
) |
|
(84 |
) |
|
(64 |
) |
|
(93 |
) |
|
(102 |
) |
Contributions from/(Distributions) to NCI |
(7 |
) |
|
(30 |
) |
|
(8 |
) |
|
(8 |
) |
|
(6 |
) |
|
(8 |
) |
Free cash flow(1) |
3 |
|
|
773 |
|
|
160 |
|
|
375 |
|
|
311 |
|
|
(73 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Net sales |
2,337 |
|
|
9,544 |
|
|
2,204 |
|
|
2,419 |
|
|
2,532 |
|
|
2,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Free cash flow as % of Net sales |
0.1 |
% |
|
8.1 |
% |
|
7.3 |
% |
|
15.5 |
% |
|
12.3 |
% |
|
(3.1 |
)% |
______________________________ |
|
(1) |
Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures. |
Table 6 |
|||||||||||
Cash Dividends Received - Unaudited |
|||||||||||
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|
(In $ millions) |
||||||||||
Dividends from equity method investments |
54 |
|
139 |
|
47 |
|
40 |
|
21 |
|
31 |
Dividends from equity investments without readily determinable fair values |
1 |
|
122 |
|
40 |
|
40 |
|
41 |
|
1 |
Total |
55 |
|
261 |
|
87 |
|
80 |
|
62 |
|
32 |
Table 7 |
|||||||||||||||||
Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited |
|||||||||||||||||
|
Q1 '26 |
|
2025 |
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
||||||
|
(In $ millions) |
||||||||||||||||
Short-term borrowings and current installments of long-term debt - third party and affiliates |
1,741 |
|
|
1,204 |
|
|
1,204 |
|
|
1,199 |
|
|
252 |
|
|
406 |
|
Long-term debt, net of unamortized deferred financing costs |
10,813 |
|
|
11,394 |
|
|
11,394 |
|
|
11,655 |
|
|
12,689 |
|
|
12,378 |
|
Total debt |
12,554 |
|
|
12,598 |
|
|
12,598 |
|
|
12,854 |
|
|
12,941 |
|
|
12,784 |
|
Cash and cash equivalents |
(1,758 |
) |
|
(1,263 |
) |
|
(1,263 |
) |
|
(1,440 |
) |
|
(1,173 |
) |
|
(951 |
) |
Net debt |
10,796 |
|
|
11,335 |
|
|
11,335 |
|
|
11,414 |
|
|
11,768 |
|
|
11,833 |
|
Table 8 |
||||||||||||||||
Certain Items - Unaudited |
||||||||||||||||
The following Certain Items attributable to |
||||||||||||||||
|
Q1 '26 |
|
2025 |
|
|
Q4 '25 |
|
Q3 '25 |
|
Q2 '25 |
|
Q1 '25 |
|
Income Statement Classification |
||
|
(In $ millions) |
|
|
|||||||||||||
Exit and shutdown costs |
44 |
|
|
98 |
|
|
29 |
|
|
10 |
|
27 |
|
32 |
|
Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Non-operating pension and other postretirement employee benefit (expense) income |
Asset impairments |
— |
|
|
1,513 |
|
|
27 |
|
(1) |
1,486 |
(2) |
— |
|
— |
|
Cost of sales / Other (charges) gains, net |
Impact from plant incidents and natural disasters |
11 |
|
|
3 |
|
|
— |
|
|
— |
|
— |
|
3 |
|
Cost of sales |
Mergers, acquisitions and dispositions |
15 |
|
|
52 |
|
|
23 |
|
|
12 |
|
12 |
|
5 |
|
Cost of sales / SG&A |
Actuarial (gain) loss on pension and postretirement plans |
— |
|
|
(49 |
) |
|
(49 |
) |
|
— |
|
— |
|
— |
|
Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income |
Legal settlements and commercial disputes |
3 |
|
|
17 |
|
|
1 |
|
|
11 |
|
2 |
|
3 |
|
Cost of sales / SG&A / Other (charges) gains, net |
(Gain) loss on disposition of businesses and assets |
(50 |
) |
|
— |
|
|
— |
|
|
— |
|
— |
|
— |
|
Gain (loss) on disposition of businesses and assets, net |
Other |
— |
|
|
5 |
|
|
3 |
|
|
1 |
|
1 |
|
— |
|
Cost of sales / SG&A |
Certain Items attributable to |
23 |
|
|
1,639 |
|
|
34 |
|
|
1,520 |
|
42 |
|
43 |
|
|
______________________________ |
|
(1) |
Related to impairment of certain long-lived assets arising from unused parcels of property subsequently sold. |
(2) |
Related to impairment of goodwill and certain trade names, primarily Zytel®, arising from our annual goodwill and indefinite-lived intangible assets impairment tests. |
Table 9 |
||||||
Return on |
||||||
|
|
|
|
|
2025 |
|
|
|
|
|
|
(In $ millions, except percentages) |
|
Net earnings (loss) attributable to |
|
|
|
|
(1,165 |
) |
|
|
|
|
|
|
|
Adjusted EBIT (Table 1) |
|
|
|
|
1,150 |
|
Adjusted effective tax rate (Table 3a) |
|
|
|
|
8 |
% |
Adjusted EBIT tax effected |
|
|
|
|
1,058 |
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
Average |
|
|
(In $ millions, except percentages) |
|||||
Short-term borrowings and current installments of long-term debt - third parties and affiliates |
1,204 |
|
1,501 |
|
1,353 |
|
Long-term debt, net of unamortized deferred financing costs |
11,394 |
|
11,078 |
|
11,236 |
|
|
4,049 |
|
5,129 |
|
4,589 |
|
Invested capital |
|
|
|
|
17,178 |
|
|
|
|
|
|
|
|
Return on invested capital (adjusted) |
|
|
|
|
6.2 |
% |
|
|
|
|
|
|
|
Net earnings (loss) attributable to |
|
|
|
|
(6.8 |
)% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260501786493/en/
Investor Relations
Phone: +1 302 772 5231
william.cunningham@celanese.com
Media -
Phone: +1 972 443 4400
media@celanese.com
Media -
Petra Czugler
Phone: +49 69 45009 1206
petra.czugler@celanese.com
Phone: +86 21 3861 9368
maria.xia@celanese.com
Source: